Skip to content
Recall Observatory FDA recall evidence

Drug product

Amikacin Sulfate Injection USP 1 gram/4mL (250mg/ML), 4 mL single-dose vials, Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0703-9040-01

D-0733-2021

July 29, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 88442
Status
Terminated
Classification
Class II
Quantity
4,712 vials
Official record key
drug-enforcement:D-0733-2021

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #: 31329243B, exp. date 05/2022

Distribution pattern: Product was distributed Nationwide, including Puerto Rico.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility